Approximately 7.6 million individuals in the United States suffer from opioid use disorder (OUD). Three evidence-based medications—methadone, buprenorphine, and naltrexone—are recommended for use by ...

The FDA approved prescription suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults, the agency announced Thursday.

Pain management doctors focus on helping a person find relief from pain due to underlying conditions or as long-term consequences of surgical procedures. Pain management doctors work with a variety of ...

Pain has the potential to affect various aspects of a person’s life, from disrupting one’s daily routine to negatively impacting emotional well-being. It’s also one of the most common reasons that ...

The current retrospective chart review found a significant difference in pain management between non-Hispanic/Latino White patients and racial/ethnic minority patients and women. Non-Hispanic/Latino ...

Credit: Getty Images. Although the clinical presentation of acute pancreatitis may vary, the most common symptom occurring in 95% of cases is deep epigastric pain that radiates to the back.

Lower back pain is one of the most common ailments, with four out of five people experiencing it at some point in their lives, according to the website for the Cleveland Clinic in Cleveland, Ohio. For ...

ORLANDO, Fla. — Recurrent pain episodes are the leading reason for emergency department (ED) visits among patients with sickle cell disease, but adherence to established acute pain management ...

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...

Physical activity stimulates the release of endorphins (natural painkillers) and promotes the production of anti-inflammatory ...